Dx Method Exemption, Clearinghouses Proposed as Solutions for Gene Patent Issues | GenomeWeb

By Matt Jones

NEW YORK (GenomeWeb News) – While judgments in US court decisions may greatly influence the gene patenting landscape, significant issues will remain regardless of those verdicts that could be addressed by changes to the patent systems, according to a new Policy Forum article in Science.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.